PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
22-Oct-2024 Wainzua (eplontersen) recommended for approval in the EU by CHMP for the treatment of adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis AstraZeneca
22-Oct-2024 Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare Sanofi
18-Oct-2024 Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials Medidata
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Inc
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi
18-Oct-2024 PUBLICATION DEMONSTRATES POTENTIAL FOR MULTI-MARKER CTC PROFILING IN EARLY PROSTATE CANCER ANGLE plc
18-Oct-2024 Yourgene Health Cystic Fibrosis Base Assay Receives IVDR Accreditation Yourgene Health
18-Oct-2024 SciRhom Initiates Dosing in First-in-Man Clinical Study Evaluating the Company’s Lead Development Program SR-878 SciRhom GmbH
18-Oct-2024 Sanofi and Orano join forces to develop next-generation radioligand medicines Sanofi and Orano Med
18-Oct-2024 EVERSANA Named a Great Place to Work for Six Consecutive Years; Now Certified Across Nine Countries EVERSANA
18-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Ltd
18-Oct-2024 Blue Mountain Announces Launch of Blue Mountain University: A Premier e-Learning Experience for RAM Software Users Blue Mountain
18-Oct-2024 Genomics releases new research showing significant link between genetic risk and obesity Genomics plc
18-Oct-2024 Mastering the Essentials: Core Topics in Clinical Research Courses Fusion Technology Solutions
16-Oct-2024 ViiV Healthcare shows more than 99% effectiveness in real-world studies for Apretude (cabotegravir long-acting), the only approved long-acting HIV PrEP, in data presented at IDWeek 2024 ViiV Healthcare
16-Oct-2024 HUTCHMED announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial HUTCHMED
16-Oct-2024 53Biologics Awarded Best Company in Biotechnology Innovation at Farmaforum 53Biologics
16-Oct-2024 Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing Cytosurge AG
16-Oct-2024 Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows Refeyn
15-Oct-2024 Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study Nipocalimab